https://www.selleckchem.com/pr....oducts/2-3-cgamp.htm
Monitoring CMV-specific Cell-mediated immunity (CMV-CMI) has been shown to be useful predicting late-onset CMV infection in different solid organ transplants, but few data has been reported after Lung Transplantation (LT). CMV-CMI against two major CMV antigens (IE-1, pp65) was evaluated in 60 seropositive LT at 6-month prophylaxis withdrawal. LT with late-onset CMV infection showed significantly lower (IE-1)CMV-CMI than patients who did not (p=0.045), being more evident in patients developing high viral loads (p=0.01. Notably, (IE-
Like
Comment
Share
